Eptifibatide (Integrilin)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Integrilin.

Indications

Dosage

0/5 ug/kg/min for 12 hours

Injection: 0.75 mg/mL

Mechanism of action

More general terms

Additional terms

References

  1. Kaiser Permanente Northern California Regional Drug Formulary, 2000
  2. 2.0 2.1 Journal Watch 22(6):47, 2002 Boersma E, Harrington RA, Moliterno DJ et al Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet. 2002 Jan 19;359(9302):189-98 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11812552
  3. Giugliano RP, White JA, Bode C et al Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med. 2009 May 21;360(21):2176-90. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19332455
  4. 4.0 4.1 4.2 NEJM Knowledge+ Question of the Week. Nov 19, 2019 https://knowledgeplus.nejm.org/question-of-week/53/
  5. 5.0 5.1 Medical Knowledge Self Assessment Program (MKSAP) 16, 19 American College of Physicians, Philadelphia 2012, 2022

Database